🇺🇸

US SEC Filing Intelligence

· daily

US Executive Compensation Proxy SEC Filings — June 25, 2026

The 15 proxy filings reveal a mix of corporate actions and governance shifts, with a notable cluster of reincorporation proposals (Trulieve, Granite Ridge) and sub-adviser changes (Liberty All Star funds) signaling strategic restructuring. Period-over-period compensation data shows sharp divergence: Kingstone's CEO pay surged 61.5% YoY driven by stock awards (+345%), while Palatin froze equity grants entirely. Portfolio liquidation trends at TCW Direct Lending (portfolio down to $249.7M, 5 debt obligors) contrast with Anterix's zero-debt balance sheet and $127M in contracted proceeds. Insider trading activity is sparse across filings, but the absence of insider selling at Anterix and McGraw Hill supports management confidence post-IPO. Forward-looking catalysts include August 2026 annual meetings for 10 companies, with key votes on reverse splits (CytoSorbents), stock plan expansions (Anterix, PetMed), and auditor ratifications. The most material development is Trulieve's redomiciliation to Delaware, which could unlock institutional ownership and tax benefits, while TCW's winding-down extension highlights terminal risk in BDC structures.

15 high priority 15 total filings
· daily

US IPO Pipeline SEC S-1 Filings — June 25, 2026

The IPO pipeline is active with four S-1/S-4 filings on June 25, 2026, spanning utilities, community banking, sustainable fashion, and biotech. A key theme is the predominance of secondary offerings by selling shareholders (Lincoln Bancorp, Reformation Inc.), indicating early investors seeking liquidity rather than primary capital raises. Period-over-period data reveals a mixed financial picture: Jersey Central Power & Light shows a concerning 29.4% decline in short-term cash investments, while Creative Medical Technology remains pre-revenue with no commercial activity. Reformation Inc. stands out as the highest-quality IPO candidate given its consumer brand and NYSE listing plans, but the lack of financial disclosures in the preliminary filing limits analysis. The biotech sector is represented by Creative Medical Technology, which carries high risk/reward given regulatory milestones but zero revenue. Overall, the pipeline lacks a blockbuster IPO, suggesting cautious market sentiment for new issuances.

4 high priority 4 total filings
· daily

US SEC Trading Suspension Halt Orders — June 25, 2026

The two filings today represent a stark contrast in trading suspension/delisting outcomes within the Nasdaq ecosystem. Global Interactive Technologies (GITS) successfully resolved its compliance deficiency, confirming a de-listing risk reversal that provides a clean bill of health for its listing status. Conversely, Heron Therapeutics (HRTX) faces a new, acute price-based delisting threat, with its stock trading below the $1.00 minimum bid threshold. The key divergence lies in the root cause: GITS faced a procedural (filing) issue which was cured, while HRTX faces a fundamental market valuation challenge. The absence of strong insider buying or operational catalysts at Heron Therapeutics amplifies the risk of a forced reverse stock split and potential eventual delisting if the stock price fails to recover. The patterns highlight that while procedural compliance can be restored through administrative action, price-based non-compliance requires market-driven solutions, making it a more challenging obstacle.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — June 25, 2026

The 44 filings reveal a significant wave of executive and director changes across US-listed companies, with a notable concentration of CEO and CFO transitions in the energy and industrial sectors. Key themes include strategic leadership refreshment, often tied to major corporate actions like acquisitions (Worthington Steel, KDP separation) or operational pivots (Prairie Operating, Reliance Global Group). Period-over-period data from Worthington Steel shows a stark contrast: 12% revenue growth driven by acquisitions versus a net loss due to $94.5M in impairment charges, highlighting the risks of aggressive M&A. Insider compensation adjustments, particularly backloaded equity awards (Curbline Properties, Grindr), signal strong retention efforts but also create potential overhang. Shareholder dissent is a recurring red flag, with several companies (eHealth, NextCure, CoStar) seeing notable opposition to equity plan amendments and say-on-pay proposals, indicating governance concerns. The most critical development is the concentration of power at AEN Group, where one individual now holds four officer titles, a significant governance red flag. Overall, the market is seeing a generational shift in leadership, with deep implications for corporate strategy and shareholder value.

44 high priority 44 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 25, 2026

The June 25, 2026, filing batch reveals a bifurcated corporate landscape: while several companies are successfully accessing capital markets (Robinhood's $2.2B zero-coupon note, SharonAI's $1.6B raise) and executing strategic M&A (onsemi's $7B acquisition of Synaptics, PetVivo's acquisition of PiezoBioMembrane), a significant cohort is exhibiting acute distress signals. Multiple companies are teetering on the brink of bankruptcy or delisting, evidenced by Americas CarMart's waiver of anticipated defaults with a September 2026 deadline, Heron Therapeutics' Nasdaq bid price deficiency, and the high-risk 12% coupon on New Fortress Energy's Brazilian notes. The period-over-period data, where available, shows a stark contrast: Blue Owl Real Estate's 15% YoY revenue growth is overshadowed by an 87.5% decline in net realized gains, while Aytu BioPharma's Metadate CD product generated only $49,000 in quarterly revenue before its license was terminated. A critical theme is the prevalence of related-party and insider transactions (DSS/Alset, TerrAscend) that raise governance concerns, particularly as companies seek emergency financing. The overall sentiment is mixed, with a clear divergence between well-capitalized firms pursuing growth and cash-strapped entities fighting for survival.

50 high priority 50 total filings
· daily

US Corporate Board Director Changes SEC Filings — June 25, 2026

The 44 filings for June 25, 2026, reveal a dynamic landscape of board and C-suite changes, with a clear emphasis on strategic appointments to drive growth in technology, energy, and healthcare sectors. A notable trend is the high volume of insider activity, including CEO and CFO transitions, often accompanied by significant equity-based compensation tied to performance milestones, signaling strong alignment with shareholder value. However, several filings also highlight shareholder dissent on executive compensation and equity plan amendments, with approval rates as low as 65.5% and 64.8%, indicating governance friction. The data shows a mix of bullish signals from companies like Planet Fitness and Archrock, which are appointing seasoned leaders with proven track records, and bearish flags from firms like Worthington Steel, which posted a net loss despite revenue growth due to impairment charges. Overall, the period is marked by proactive board restructuring to navigate sector-specific challenges, with a particular focus on AI integration, energy transition, and operational efficiency.

44 high priority 44 total filings
· daily

USA Insider Trading Pulse — June 25, 2026

The June 25, 2026, insider trading filings reveal a market dominated by routine compensation awards and passive position reporting, masking several high-conviction signals. The most significant event is a massive $248M sale by Mantle Ridge LP in **DOLLAR TREE, INC.**, a 10% owner, which represents a major bearish signal for the discount retail sector. Conversely, open-market buying is scarce but notable, with two directors at **Sixth Street Lending Partners** making small, coordinated purchases, and a 10% owner at **MEXICO FUND INC** adding to a position. The period is marked by several planned insider sales under 10b5-1 plans at **Sea Ltd**, **Global-E Online**, **GALECTIN THERAPEUTICS**, **Monte Rosa Therapeutics**, and **PC CONNECTION**, indicating pre-arranged diversification. A cluster of director stock awards at **HYDROFARM HOLDINGS GROUP** and **Foghorn Therapeutics** suggests a focus on board retention. The overall sentiment is mixed, with a bearish tilt from large-scale selling and a lack of bullish open-market buying, but the prevalence of neutral compensation events tempers the negative outlook.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — June 25, 2026

The USA M&A & Takeover Activity stream for June 25, 2026, reveals a market bifurcated between high-conviction, large-scale take-private deals and struggling SPACs facing deadline pressures and shareholder dissent. The most material event is the $8.4 billion take-private of Clearwater Analytics at a 47% premium, signaling strong private equity appetite for quality tech assets. Conversely, the SPAC sector shows significant stress: BPGC's merger with iRocket has collapsed, Flag Ship and Launch One face shareholder redemptions and extension votes, and Cayson has pushed its deadline for a third time. However, positive signals emerge from Live Oak's successful $525 million combination with Teamshares and Real Asset's shareholder approval of a quantum computing merger, though the latter saw only 63% turnout. A notable trend is the strategic pivot of smaller companies like Gaxos.ai and HeartCore, which are divesting non-core assets to focus on higher-margin AI and advisory services. The period-over-period data is limited for these event-driven filings, but the forward-looking data and insider activity (or lack thereof) provide clear signals: sponsor support and shareholder patience are waning for many SPACs, while private equity remains aggressive for proven platforms.

14 high priority 14 total filings
· monthly

US Pre-Market SEC Filings Roundup — June 25, 2026

Overnight filings reveal a market bifurcated between aggressive insider selling at growth-stage tech firms and strategic capital deployment in energy and quantum sectors. The most significant development is GigCapital8's non-binding LOI to acquire Quantisimo Corp. at a ~$575M pre-money valuation, creating a pure-play quantum company, which carries high execution risk. Insider selling is concentrated at Hinge Health ($19M+ by a 10% owner), Helios Technologies ($545K by a president), and Domo ($516K combined by C-suite), signaling potential management concern at elevated valuations or ahead of headwinds. Conversely, a $50M insider purchase at Kardigan and a $124K buy at Patrick Industries suggest strong conviction in value. On the corporate action front, LakeShore Biopharma's merger completion at a de minimis $0.066/share cash consideration represents a total loss for minority holders, while Enlight Renewable Energy's project-level guidance implies an 80%+ EBITA margin, a standout in the infrastructure space. The period-over-period data is limited in these filings, but the mix of insider activity and forward-looking statements points to a cautious tone in tech and biotech, with selective conviction in energy and industrial niches.

35 high priority 15 medium 50 total filings
· daily

Federal Construction & Infrastructure Contracts — June 24, 2026

This digest covers a single $74.4 million civilian infrastructure contract awarded by the FAA to Walsh Federal LLC for construction of an air traffic control tower in Grand Forks, ND. The award is a firm-fixed-price, full-and-open competition win, signaling continued federal investment in air traffic control infrastructure but with high execution risk transferred to the contractor. The neutral signal strength (5/10) reflects the lack of defense exposure, competitive moat, or set-aside preference. Key watch items include cost overrun risk on the fixed-price structure and potential for future FAA tower awards to establish repeat business patterns.

1 total filings
· daily

VA Healthcare & Services Contracts — June 24, 2026

The two VA contracts totaling $171.2 million reveal a civilian-agency spending story focused on healthcare services and IT modernization, with zero defense exposure. The highest-conviction signal is SAIC's $77.6 million IT operations award (potential $205.5 million with options), a bullish indicator of sustained VA IT investment. QTC Medical Services' $93.6 million fixed-price delivery order carries neutral weight due to short duration and minimal outlays. Key risk: QTC's contract has only $878,312 outlayed, implying execution or option delays that could limit near-term revenue for Leidos.

2 total filings
· daily

New Federal Contractors — June 24, 2026

This digest covers 9 federal contracts awarded on a single day, totaling $834.7 million, with only 1 of 9 being defense-related, reflecting a strong civilian agency tilt. The dominant agency theme is civilian IT services, with the Department of State, Department of Veterans Affairs, and NASA accounting for roughly half the aggregate value. The highest-conviction signal is SAIC’s two bullish contract wins ($159.1M combined) under full-and-open competition, signaling sustained competitive strength in federal IT. A key risk is the high concentration of awards to Leidos and its subsidiary QTC Medical Services ($260.6M combined), which creates revenue concentration risk for Leidos if these contracts face protest or budget cuts. Investors should monitor option exercise announcements for SAIC’s NITES contract and Leidos’ CMS hosting contract, as these are the key drivers of multi-year revenue visibility.

9 total filings
· daily

Significant Contract Modifications ($10M+) — June 24, 2026

This digest covers 9 government contract modifications totaling $834.7 million, with only 1 of 9 being defense-related, underscoring a pronounced civilian-agency tilt. The Department of Health and Human Services (Leidos, $167M), NASA (Caltech, $108M), and the Department of Veterans Affairs (QTC Medical/Leidos, $93.6M; SAIC, $77.6M) dominate the award pool, signaling robust IT and healthcare services spending outside the Pentagon. The highest-conviction signal is SAIC’s two bullish awards ($159M combined) for IT services at GSA and VA, both with multi-year option structures that provide revenue visibility through 2031. A key risk is the high concentration of time-and-materials and firm-fixed-price contracts, which transfer cost overrun risk to contractors, particularly for Walsh Federal ($74.4M FAA tower construction) and General Dynamics IT ($73.2M State Department compute services).

9 total filings
· daily

Contract Deobligations Alert — June 24, 2026

This digest of nine contracts totaling $834.7M reveals a predominantly civilian-sector procurement environment, with only one defense-related award. The dominant theme is federal IT services modernization, with SAIC and Leidos capturing the largest competitive wins—SAIC secured two contracts worth a combined $159.1M (base values) from GSA and VA, while Leidos won a $167M CMS hosting deal. The highest-conviction signal is SAIC's cost-plus award fee NITES contract with GSA FEDSIM, which offers low pricing risk and long-term revenue visibility through 2031. Key risks include Walsh Federal's firm-fixed-price FAA tower construction contract ($74.4M) with high execution risk, and the heavy civilian agency concentration (8 of 9 contracts) which exposes the portfolio to continuing resolution uncertainty in Q4 2026.

9 total filings
· daily

Contract Option Exercises — June 24, 2026

This digest of 9 contract option exercises totaling $834.7M reveals a pronounced civilian agency focus, with only 1 of 9 awards defense-related. The Department of State leads with two awards totaling $147.6M, while the Department of Veterans Affairs accounts for $171.2M across two contracts. The highest-conviction signal is SAIC's dual wins ($159.1M combined) under cost-plus and time-and-materials structures, offering stable margins and multi-year revenue visibility through 2031. Key risk: the aggregate includes only one defense contract, limiting exposure to DOD's more durable funding streams, and the QTC Medical Services award shows only $878K outlaid against a $93.6M obligation, suggesting execution or funding delays.

9 total filings
· daily

Federal IT & Cybersecurity Contracts — June 24, 2026

Over a single-day snapshot, $559 million in federal IT and cybersecurity contracts were awarded, with only one of six contracts being defense-related, underscoring a pronounced civilian-agency tilt. The Department of Health and Human Services (CMS) led with a $167M Leidos award, while SAIC captured two contracts totaling $159M from the GSA and VA, signaling strong competitive positioning in civilian IT services. The highest-conviction signal is SAIC's $81.5M GSA FEDSIM NITES contract, which carries low pricing risk (cost-plus award fee) and long-term revenue visibility through 2031. A key risk is the concentration of awards among a few large primes (Leidos, SAIC, GDIT) and the reliance on option exercises for ~60% of the total potential value, exposing investors to budget uncertainty under a potential Continuing Resolution.

6 total filings
· daily

NASA & Space Contracts Intelligence — June 24, 2026

The single contract analyzed, valued at $107.7 million, is entirely civilian (NASA) and represents a long-term, cost-no-fee award to the California Institute of Technology for the SPHEREx astrophysics mission. The signal is neutral, as the nonprofit recipient generates no profit from the contract, limiting direct equity upside for investors. The dominant theme is NASA’s sustained investment in space-based scientific surveys, but the lack of defense exposure and the non-profit structure mute near-term actionable signals. A key risk is the cost-no-fee pricing structure, which places financial risk on Caltech if costs exceed obligations, though $93.5 million has already been disbursed.

1 total filings
· daily

All HHS Contracts — June 24, 2026

This digest covers a single civilian contract from the Department of Health and Human Services (HHS) totaling $167 million, with zero defense-related awards. The dominant theme is HHS/CMS IT infrastructure modernization, as Leidos secured a time-and-materials delivery order to host and support over 300 business applications through 2027. The neutral signal (strength 5/10) reflects steady revenue visibility for Leidos but modest materiality relative to its $15B annual revenue. Key risk includes medium pricing risk from the time-and-materials structure and potential budget uncertainty under a continuing resolution (CR) scenario affecting CMS funding. The contract reinforces Leidos' competitive position in civilian health IT but offers limited near-term upside for investors.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — June 24, 2026

Over the single-day period of June 24, 2026, the Mega Contracts Monitor recorded $274.7 million in total obligations across two contracts, both civilian in nature with zero defense-related awards. The dominant theme is civilian IT modernization and space science, led by a $167M Leidos time-and-materials delivery order from CMS for hosting over 300 business applications, and a $107.7M Caltech cost-no-fee contract from NASA for the SPHEREx astrophysics mission. The highest-conviction signal is the Leidos award, which reinforces its competitive position in health IT but carries medium pricing risk due to the time-and-materials structure. A key risk is the cost-no-fee nature of the Caltech contract, which limits direct equity upside for investors despite the large ceiling.

2 total filings
· daily

High-Value Federal Grants ($5M+) — June 24, 2026

This digest covers $834.7 million in high-value contracts awarded between June 2026 and five earlier awards from 2018–2024, with only 1 of 9 contracts defense-related ($77.6M SAIC VA contract, not directly DOD). The dominant theme is civilian agency IT modernization, with $414.5M concentrated across Leidos, SAIC, GDIT, and smaller firms at HHS/CMS, VA, DOJ, DOS, and GSA. The highest-conviction signal is Network Designs' $85.3M SDVOSB set-aside win at DOJ (materiality 7/10, bullish), signaling durable small-business IT demand. Key risk: QTC Medical Services' $93.6M VA award has only 0.9% outlayed, raising execution or budget-risk questions.

9 total filings